Wall Street analysts expect that Proto Labs Inc (NYSE:PRLB) will report $119.63 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Proto Labs’ earnings. The lowest sales estimate is $118.90 million and the highest is $120.00 million. Proto Labs posted sales of $115.43 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 3.6%. The firm is scheduled to announce its next quarterly earnings results on Thursday, October 24th.

According to Zacks, analysts expect that Proto Labs will report full year sales of $467.40 million for the current year, with estimates ranging from $463.50 million to $470.70 million. For the next fiscal year, analysts expect that the company will report sales of $508.70 million, with estimates ranging from $497.60 million to $514.80 million. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Proto Labs.

Proto Labs (NYSE:PRLB) last posted its earnings results on Thursday, July 25th. The industrial products company reported $0.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.02. Proto Labs had a return on equity of 13.14% and a net margin of 15.71%. The company had revenue of $115.90 million during the quarter, compared to the consensus estimate of $116.49 million. During the same quarter last year, the firm earned $0.73 earnings per share. The company’s revenue was up 5.7% on a year-over-year basis.

PRLB has been the subject of a number of analyst reports. ValuEngine raised Proto Labs from a “hold” rating to a “buy” rating in a research note on Tuesday. Piper Jaffray Companies dropped their price target on Proto Labs from $92.00 to $84.00 and set a “neutral” rating for the company in a research note on Thursday, July 25th. Finally, Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $117.00 price target for the company in a research note on Thursday, August 1st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $126.25.

Shares of PRLB traded down $0.14 during midday trading on Monday, reaching $109.46. 245,200 shares of the stock were exchanged, compared to its average volume of 185,505. Proto Labs has a twelve month low of $88.75 and a twelve month high of $166.60. The company has a quick ratio of 4.08, a current ratio of 4.26 and a debt-to-equity ratio of 0.02. The company has a market cap of $2.78 billion, a P/E ratio of 38.95, a PEG ratio of 1.29 and a beta of 1.65. The stock’s 50 day simple moving average is $97.76 and its 200 day simple moving average is $105.28.

A number of hedge funds have recently bought and sold shares of PRLB. TimesSquare Capital Management LLC raised its stake in Proto Labs by 173.3% in the second quarter. TimesSquare Capital Management LLC now owns 356,380 shares of the industrial products company’s stock valued at $41,347,000 after purchasing an additional 225,980 shares in the last quarter. ARK Investment Management LLC raised its stake in Proto Labs by 273.5% in the first quarter. ARK Investment Management LLC now owns 291,222 shares of the industrial products company’s stock valued at $30,619,000 after purchasing an additional 213,256 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its stake in Proto Labs by 5,004.9% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 164,685 shares of the industrial products company’s stock worth $19,107,000 after acquiring an additional 161,459 shares in the last quarter. Nikko Asset Management Americas Inc. raised its stake in Proto Labs by 5,090.0% during the second quarter. Nikko Asset Management Americas Inc. now owns 164,471 shares of the industrial products company’s stock worth $19,082,000 after acquiring an additional 161,302 shares in the last quarter. Finally, Morgan Stanley raised its stake in Proto Labs by 140.0% during the second quarter. Morgan Stanley now owns 194,452 shares of the industrial products company’s stock worth $22,560,000 after acquiring an additional 113,444 shares in the last quarter. 93.87% of the stock is owned by institutional investors and hedge funds.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.

See Also: What causes a recession?

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.